These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30160337)

  • 1. Genomewide association study reveals novel genetic loci associated with change in renal function in heart transplant recipients.
    Asleh R; Snipelisky D; Hathcock M; Kremers W; Liu D; Batzler A; Jenkins G; Kushwaha S; Pereira NL
    Clin Transplant; 2018 Oct; 32(10):e13395. PubMed ID: 30160337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration rate: Analysis of 593 combined heart-kidney transplants from the United Network Organ Sharing Database.
    Karamlou T; Welke KF; McMullan DM; Cohen GA; Gelow J; Tibayan FA; Mudd JM; Slater MS; Song HK
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):456-461.e1. PubMed ID: 24183335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population.
    Stapleton CP; Heinzel A; Guan W; van der Most PJ; van Setten J; Lord GM; Keating BJ; Israni AK; de Borst MH; Bakker SJL; Snieder H; Weale ME; Delaney F; Hernandez-Fuentes MP; Reindl-Schwaighofer R; Oberbauer R; Jacobson PA; Mark PB; Chapman FA; Phelan PJ; Kennedy C; Sexton D; Murray S; Jardine A; Traynor JP; McKnight AJ; Maxwell AP; Smyth LJ; Oetting WS; Matas AJ; Mannon RB; Schladt DP; Iklé DN; Cavalleri GL; Conlon PJ; ; ;
    Am J Transplant; 2019 Aug; 19(8):2262-2273. PubMed ID: 30920136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients.
    Grupper A; AbouEzzeddine OF; Maleszewski JJ; Grupper A; Geske JR; Kremers WK; Kushwaha SS; Pereira NL
    Clin Transplant; 2018 Sep; 32(9):e13349. PubMed ID: 29998506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients.
    Groetzner J; Kaczmarek I; Landwehr P; Mueller M; Daebritz S; Lamm P; Meiser B; Reichart B
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):333-41. PubMed ID: 15019657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy.
    Helmschrott M; Rivinius R; Bruckner T; Katus HA; Doesch AO
    Drug Des Devel Ther; 2017; 11():1673-1680. PubMed ID: 28652705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation.
    Grupper A; Grupper A; Daly RC; Pereira NL; Hathcock MA; Kremers WK; Cosio FG; Edwards BS; Kushwaha SS
    J Heart Lung Transplant; 2017 Mar; 36(3):297-304. PubMed ID: 27642059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neutrophil gelatinase-associated lipocalin and worsening renal function during everolimus therapy after heart transplantation.
    Imamura T; Kinugawa K; Doi K; Hatano M; Fujino T; Kinoshita O; Nawata K; Noiri E; Kyo S; Ono M
    Int Heart J; 2015; 56(1):73-9. PubMed ID: 25742944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients.
    Lachance K; Barhdadi A; Mongrain I; Normand V; Zakrzewski M; Leblanc MH; Racine N; Carrier M; Ducharme A; Turgeon J; Dubé MP; Phillips MS; White M; de Denus S
    Pharmacogenet Genomics; 2012 May; 22(5):336-43. PubMed ID: 22322241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of iron deficiency and anemia in pediatric heart transplant recipients.
    Newland DM; Spencer KL; Do LD; Knorr LR; Palmer MM; Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Hartje-Dunn C; Mark DG; Nemeth TL; Ravi-Johnson S; Law YM
    Clin Transplant; 2024 Jun; 38(6):e15367. PubMed ID: 38809215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantation.
    Di Nora C; Sponga S; Ferrara V; Patriarca F; Fanin R; Nalli C; Lechiancole A; Vendramin I; Livi U
    J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):261-267. PubMed ID: 33633041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal outcome after simultaneous heart and kidney transplantation.
    Toinet T; Dominique I; Cholley I; Vanalderwerelt V; Goujon A; Paret F; Bessede T; Delaporte V; Salomon L; Badet L; Boutin JM; Verhoest G; Branchereau J; Timsit MO;
    Clin Transplant; 2019 Jul; 33(7):e13615. PubMed ID: 31215696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tacrolimus trough level variability is associated with rejections after heart transplant.
    Gueta I; Markovits N; Yarden-Bilavsky H; Raichlin E; Freimark D; Lavee J; Loebstein R; Peled Y
    Am J Transplant; 2018 Oct; 18(10):2571-2578. PubMed ID: 29989311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction Immunosuppression and Renal Outcomes in Adult Heart Transplantation.
    Diaz-Castrillon CE; Huckaby LV; Hickey G; Sultan I; Kilic A
    J Surg Res; 2021 Mar; 259():14-23. PubMed ID: 33278793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes in kidney function following heart transplantation: Stanford experience.
    Taiwo AA; Khush KK; Stedman MR; Zheng Y; Tan JC
    Clin Transplant; 2018 Nov; 32(11):e13414. PubMed ID: 30240515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CYP3A5 genetic variation on everolimus maintenance dosing after cardiac transplantation.
    Lesche D; Sigurdardottir V; Setoud R; Englberger L; Fiedler GM; Largiadèr CR; Mohacsi P; Sistonen J
    Clin Transplant; 2015 Dec; 29(12):1213-20. PubMed ID: 26458301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Renal Function After Heart Transplantation.
    Tsao CI; Ting M; Chou NK; Chi NH; Chen YS; Huang SC; Tsan CY; Wang CH; Yu HY; Shun CT; Wang SS
    Transplant Proc; 2018 Nov; 50(9):2751-2755. PubMed ID: 30401390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy.
    Arora S; Andreassen A; Simonsen S; Gude E; Dahl C; Skaardal R; Hoel I; Geiran O; Gullestad L
    Transplantation; 2007 Jul; 84(2):149-54. PubMed ID: 17667805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation.
    Gude E; Gullestad L; Arora S; Simonsen S; Hoel I; Hartmann A; Holdaas H; Fiane AE; Geiran OR; Andreassen AK
    J Heart Lung Transplant; 2010 Jun; 29(6):641-7. PubMed ID: 20304681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic heart disease is a risk factor for renal failure after heart transplantation.
    Hosková L; Viklický O; Málek I; Podzimková M; Hegarová M; Pirk J; Vítko S; Kautzner J
    Int J Cardiol; 2008 Jan; 123(3):358-60. PubMed ID: 17360057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.